167 related articles for article (PubMed ID: 28757964)
1. A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging.
Wu Q; Cheng Q; Yuan S; Qian J; Zhong K; Qian Y; Liu Y
Chem Sci; 2015 Nov; 6(11):6607-6613. PubMed ID: 28757964
[TBL] [Abstract][Full Text] [Related]
2. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
3. Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imaging.
Zhao H; Zhao H; Jiao Y; Zhu Y; Liu C; Li F; Wang Y; Gu Z; Yang D
Biomaterials; 2020 Oct; 256():120220. PubMed ID: 32736168
[TBL] [Abstract][Full Text] [Related]
4. Gd-DTPA-coupled Ag
Ma JJ; Yu MX; Zhang Z; Cai WG; Zhang ZL; Zhu HL; Cheng QY; Tian ZQ; Pang DW
Nanoscale; 2018 Jun; 10(22):10699-10704. PubMed ID: 29845127
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance/fluorescence dual-modality contrast agents targeting α
Yin Q; Qi G; Wang S; Tian H; Gao X; Zhang Z; Hao L
Biochem Biophys Res Commun; 2023 Jul; 664():86-93. PubMed ID: 37141641
[TBL] [Abstract][Full Text] [Related]
6. Tailoring encodable lanthanide-binding tags as MRI contrast agents.
Daughtry KD; Martin LJ; Sarraju A; Imperiali B; Allen KN
Chembiochem; 2012 Nov; 13(17):2567-74. PubMed ID: 23150430
[TBL] [Abstract][Full Text] [Related]
7. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Mediated Biomineralization of Paramagnetic NIR Ag2S QDs for Tiny Tumor Bimodal Targeted Imaging in Vivo.
Zhang J; Hao G; Yao C; Yu J; Wang J; Yang W; Hu C; Zhang B
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16612-21. PubMed ID: 27300300
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
[TBL] [Abstract][Full Text] [Related]
10. The influence of Gd-DOTA conjugating ratios to PLGA-PEG micelles encapsulated IR-1061 on bimodal over-1000 nm near-infrared fluorescence and magnetic resonance imaging.
Doan TKD; Umezawa M; Ohnuki K; Nigoghossian K; Okubo K; Kamimura M; Yamaguchi M; Fujii H; Soga K
Biomater Sci; 2022 Mar; 10(5):1217-1230. PubMed ID: 35072181
[TBL] [Abstract][Full Text] [Related]
11. Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging.
Xiao X; Cai H; Huang Q; Wang B; Wang X; Luo Q; Li Y; Zhang H; Gong Q; Ma X; Gu Z; Luo K
Bioact Mater; 2023 Jan; 19():538-549. PubMed ID: 35600977
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging.
Yang CT; Hattiholi A; Selvan ST; Yan SX; Fang WW; Chandrasekharan P; Koteswaraiah P; Herold CJ; Gulyás B; Aw SE; He T; Ng DCE; Padmanabhan P
Acta Biomater; 2020 Jul; 110():15-36. PubMed ID: 32335310
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
15. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
18. Preparation of gadolinium doped carbon dots for enhanced MR imaging and cell fluorescence labeling.
Zheng S; Yu N; Han C; Xie T; Dou B; Kong Y; Zuo F; Shi M; Xu K
Biochem Biophys Res Commun; 2019 Apr; 511(2):207-213. PubMed ID: 30777335
[TBL] [Abstract][Full Text] [Related]
19. A gadolinium(iii) complex based dual-modal probe for MRI and fluorescence sensing of fluoride ions in aqueous medium and in vivo.
Wang Y; Song R; Guo K; Meng Q; Zhang R; Kong X; Zhang Z
Dalton Trans; 2016 Nov; 45(44):17616-17623. PubMed ID: 27824182
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
